Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients With Multidrug-Resistant Gram-Negative Bacterial Infections-Reference-Cited by-同舟云学术

Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients With Multidrug-Resistant Gram-Negative Bacterial Infections

Published:2020-06-05 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Wang Peile,Zhang Qiwen,Zhu Zhenfeng,Feng Min,Sun Tongwen,Yang Jing,Zhang Xiaojian

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference32 articles.

1. Pharmacokinetics and renal disposition of polymyxin B in an animal model;Abdelraouf;Antimicrob. Agents Ch.,2012

2. Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data;Abrantes;Brit J. Clin. Pharmaco.,2019

3. The optimal use of the polymyxins before their time is up;Alosaimy;Pharmacotherapy,2019

4. Polymyxin B pharmacokinetics in adult cystic fibrosis patients;Avedissian;Pharmacotherapy,2018

5. A review of the clinical pharmacokinetics of polymyxin B;Avedissian;Antibiotics,2019

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of polymixin B1, B2, ile-B1, E1, and E2 in human plasma and its clinical pharmacokinetic application;Journal of Pharmaceutical and Biomedical Analysis;2024-11

2. Outcome of intravenous and inhaled polymyxin B treatment in patients with multidrug-resistant gram-negative bacterial pneumonia;International Journal of Antimicrobial Agents;2024-10

3. A simple HPLC–MS/MS method for the determination of polymyxin B in human plasma and its application in the pharmacokinetic study in elderly patients infected with multidrug-resistant Gram-negative bacteria;Frontiers in Pharmacology;2024-08-16

4. Three methods to optimise polymyxin B dosing using estimated AUC after first dose: validation with the data generated by Monte Carlo simulation;Xenobiotica;2024-07-08

5. How can polymyxin B be dosed based on current pharmacokinetic knowledge?;European Journal of Clinical Pharmacology;2024-06-07